Rushabh M Vakharia1, Nipun Sodhi2, Hiba K Anis3, Joseph O Ehiorobo2, Michael A Mont4, Martin W Roche1. 1. Holy Cross Hospital, Orthopaedic Research Institute, Fort Lauderdale, FL. 2. Department of Orthopaedic Surgery, Lenox Hill Hospital, Northwell Health, New York, NY. 3. Department of Orthopaedic Surgery, Cleveland Clinic Hospital, Cleveland, OH. 4. Department of Orthopaedic Surgery, Lenox Hill Hospital, Northwell Health, New York, NY; Department of Orthopaedic Surgery, Cleveland Clinic Hospital, Cleveland, OH.
Abstract
BACKGROUND: Studies have shown that cannabis can interfere with hematological parameters and platelet morphology. The purpose of this study is to investigate whether patients with cannabis use disorder undergoing primary total knee arthroplasty (TKA) have higher rates of (1) venous thromboemboli (VTEs); (2) readmissions; and (3) costs. METHODS: Study group patients undergoing primary TKA were identified from a large, nationwide database. Patients who had a history of VTEs, deep vein thromboses (DVTs), pulmonary emboli (PEs), and coagulopathies before their TKA were excluded. Study group patients were matched to controls in a 1:4 ratio by age, sex, a comorbidity index, and medical comorbidities. The query yielded 18,388 patients (cannabis = 3680; controls = 14,708). Outcomes analyzed included rates of 90-day VTEs, DVTs, and PEs, in addition to 90-day readmissions and costs. A P value less than .01 was considered statistically significant. RESULTS: Patients who have cannabis use disorder were found to have significantly higher incidence and odds (2.79% vs 1.78%; odds ratio [OR], 1.58; P < .0001) of VTEs, DVTs (2.41% vs 1.44%; OR, 1.68; P < .0001), and PEs (0.97% vs 0.62%; P = .01). Readmissions were significantly higher (27.03% vs 23.18%; OR, 1.22; P < .0001) in patients who have cannabis use disorder. Patients with cannabis use disorder have significantly higher day of surgery ($14,024.88 vs $12,127.49; P < .0001) and 90-day costs ($19,155.45 vs $16,315.00; P < .0001). CONCLUSION: This study found that patients who have a cannabis use disorder have higher rates of thromboembolic complications, readmission rates, and costs following primary TKA compared to a matched cohort.
BACKGROUND: Studies have shown that cannabis can interfere with hematological parameters and platelet morphology. The purpose of this study is to investigate whether patients with cannabis use disorder undergoing primary total knee arthroplasty (TKA) have higher rates of (1) venous thromboemboli (VTEs); (2) readmissions; and (3) costs. METHODS: Study group patients undergoing primary TKA were identified from a large, nationwide database. Patients who had a history of VTEs, deep vein thromboses (DVTs), pulmonary emboli (PEs), and coagulopathies before their TKA were excluded. Study group patients were matched to controls in a 1:4 ratio by age, sex, a comorbidity index, and medical comorbidities. The query yielded 18,388 patients (cannabis = 3680; controls = 14,708). Outcomes analyzed included rates of 90-day VTEs, DVTs, and PEs, in addition to 90-day readmissions and costs. A P value less than .01 was considered statistically significant. RESULTS:Patients who have cannabis use disorder were found to have significantly higher incidence and odds (2.79% vs 1.78%; odds ratio [OR], 1.58; P < .0001) of VTEs, DVTs (2.41% vs 1.44%; OR, 1.68; P < .0001), and PEs (0.97% vs 0.62%; P = .01). Readmissions were significantly higher (27.03% vs 23.18%; OR, 1.22; P < .0001) in patients who have cannabis use disorder. Patients with cannabis use disorder have significantly higher day of surgery ($14,024.88 vs $12,127.49; P < .0001) and 90-day costs ($19,155.45 vs $16,315.00; P < .0001). CONCLUSION: This study found that patients who have a cannabis use disorder have higher rates of thromboembolic complications, readmission rates, and costs following primary TKA compared to a matched cohort.
Authors: Fernando D Albelo; Mitchell Baker; Tina Zhang; Matheus B Schneider; Julio J Jauregui; Vidushan Nadarajah; Sean J Meredith; Jonathan D Packer; R Frank Henn Journal: Int Orthop Date: 2021-05-29 Impact factor: 3.075
Authors: Libby R Copeland-Halperin; Laura C Herrera-Gomez; Jennifer R LaPier; Nina Shank; Joseph H Shin Journal: Plast Reconstr Surg Glob Open Date: 2021-03-15
Authors: Stefan Hamaway; Bana Hadid; Rushabh M Vakharia; Mitchell K Ng; Adam M Gordon; Martin W Roche; Afshin E Razi Journal: Arthroplasty Date: 2022-07-27
Authors: Vishal Hegde; Daniel N Bracey; Roseann M Johnson; Yasmin Yazdani Farsad; Douglas A Dennis; Jason M Jennings Journal: Arthroplast Today Date: 2022-09-19